{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:05:52Z","timestamp":1792037152681,"version":"4.4.0"},"reference-count":540,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.disamonth.2017.12.001","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T03:07:10Z","timestamp":1515553630000},"page":"98-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Pediatric obesity: Current concepts"],"prefix":"10.1016","volume":"64","author":[{"given":"Donald E.","family":"Greydanus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisha","family":"Agana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmohan K.","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Shebrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelkamal","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ransome","family":"Eke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9735","key":"10.1016\/j.disamonth.2017.12.001_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(10)61065-3","article-title":"A long look at obesity","volume":"376","author":"Haslam","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/gerona\/glp166","article-title":"Obesity in aging and art","volume":"65","author":"Ferrucci","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijcard.2012.01.082","article-title":"Atherosclerotic cardiovascular disease in Egyptian women: 1570 BCE-2011 CE","volume":"167","author":"Abdelfattah","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1472-6483(10)60182-4","article-title":"Obesity-associated infertility - the earliest known description","volume":"17","author":"Ben-Shlomo","year":"2008","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00268-004-7373-9","article-title":"Methods used by the Hippocratic physicians for weight reduction","volume":"28","author":"Christopoulou-Aletra","year":"2004","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00268-004-7458-5","article-title":"Galen on obesity: etiology, effects, and treatment","volume":"28","author":"Papavramidou","year":"2004","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11695-007-9017-2","article-title":"Greco-Roman and Byzantine views on obesity","volume":"17","author":"Papavramidou","year":"2007","journal-title":"Obes Surg"},{"issue":"12A","key":"10.1016\/j.disamonth.2017.12.001_bib8","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1017\/S1368980011002539","article-title":"The Middle Eastern and Biblical origins of the Mediterranean diet","volume":"14","author":"Berry","year":"2011","journal-title":"Public Health Nutr"},{"issue":"9481","key":"10.1016\/j.disamonth.2017.12.001_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(05)66907-3","article-title":"Obesity: 1000 years ago","volume":"366","author":"Abdel-Halim","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.shpsc.2011.10.029","article-title":"\u2018Abhorreas pinguedinem\u2019: Fat and obesity in early modern medicine (c. 1500-1750)","volume":"43","author":"Stolberg","year":"2012","journal-title":"Stud Hist Philos Biol Biomed Sci"},{"issue":"4-6","key":"10.1016\/j.disamonth.2017.12.001_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1758-8111.2011.00031.x","article-title":"The history of obesity","volume":"1","author":"Haslam","year":"2011","journal-title":"Clin Obes"},{"key":"10.1016\/j.disamonth.2017.12.001_bib12","doi-asserted-by":"crossref","first-page":"2460285","DOI":"10.1155\/2016\/2460285","article-title":"For researchers on obesity: historical review of extra body weight definitions","volume":"2016","author":"Komaroff","year":"2016","journal-title":"J Obes"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/nu9050519","article-title":"Evolution not revolution: nutrition and obesity","volume":"9","author":"Rush","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.disamonth.2017.12.001_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000209967","article-title":"Global changes in diet and activity patterns as drivers of the nutrition transition","volume":"63","author":"Popkin","year":"2009","journal-title":"Nestle Nutr Workshop Ser Pediatr Program"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ijcp.12771","article-title":"Weight management in obesity \u2013 past and present","volume":"70","author":"Haslam","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.disamonth.2017.12.001_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fpubh.2016.00279","article-title":"Overfat and underfat: new terms and definitions long overdue","volume":"4","author":"Maffetone","year":"2017","journal-title":"Front Public Health"},{"key":"10.1016\/j.disamonth.2017.12.001_bib17","unstructured":"Merriam-Webster. https:\/\/www.merriam-webster.com. [Assessed 3 December 2017]."},{"key":"10.1016\/j.disamonth.2017.12.001_bib18","doi-asserted-by":"crossref","unstructured":"{C}Skinner AC,\u00a0Perrin EM{C}, Skelton JA. Prevalence of obesity and severe obesity in US children, 1999-2014. Obesity (Silver Spring) 2016; 24(5):1116-1123.","DOI":"10.1002\/oby.21497"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib19","first-page":"25","article-title":"Pediatric metabolic syndrome: pathophysiology and laboratory assessment","volume":"28","author":"Higgins","year":"2017","journal-title":"EJIFCC"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib20","first-page":"20","article-title":"Commentary: which child obesity definitions predict health risk? Ital","volume":"43","author":"Lobstein","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib21","unstructured":"Sassi F, Devaux M, Cecchini M, et al. The obesity epidemic: analysis of past and projected future trends in selected OECD countries. OECD Heal Work Pap 2009;45(45)."},{"issue":"9793","key":"10.1016\/j.disamonth.2017.12.001_bib22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments","volume":"378","author":"Swinburn","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s13679-016-0187-x","article-title":"Obesity among young adults in developing countries: A systematic overview","volume":"5","author":"Poobalan","year":"2016","journal-title":"Curr Obes Rep"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/17477160600586747","article-title":"Worldwide trends in childhood overweight and obesity","volume":"1","author":"Wang","year":"2006","journal-title":"Int J Pediatr Obes"},{"key":"10.1016\/j.disamonth.2017.12.001_bib25","article-title":"Obesity Epidemiology","author":"Hu","year":"2009","journal-title":"Oxford, England: Oxford Scholarship Online"},{"key":"10.1016\/j.disamonth.2017.12.001_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","author":"Abarca-G\u00f3mez","year":"2017","journal-title":"Lancet"},{"issue":"10026","key":"10.1016\/j.disamonth.2017.12.001_bib27","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants","volume":"387","author":"Di Cesare","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2017.12.001_bib28","first-page":"w14265","article-title":"\u201cThe obesity paradox\u201d in disease\u2014is the protective effect of obesity true?","volume":"145","author":"Braun","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.disamonth.2017.12.001_bib29","first-page":"441","article-title":"Obesity","volume":"163","author":"Musaad","year":"2011","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.disamonth.2017.12.001_bib30","unstructured":"World Health Organization. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva, Switzerland [electronic article]. 2008{C}; ISBN 9789241597418 (NLM Classification: WT500)."},{"key":"10.1016\/j.disamonth.2017.12.001_bib31","unstructured":"WHO. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Heal. Organ. [electronic article]. 2013. 102. Resolution WHA66.10. http:\/\/www.who.int\/nmh\/events\/ncd_action_plan\/en\/. [Accessed: 3 December 2017]."},{"key":"10.1016\/j.disamonth.2017.12.001_bib32","unstructured":"World Health Organization. WHO | Obesity and overweight. WHO [electronic article]. 2016{C}; http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/. [Assessed 3 December 2017]."},{"issue":"Suppl 8A","key":"10.1016\/j.disamonth.2017.12.001_bib33","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/j.amjmed.2003.08.012","article-title":"Obesity as a cardiovascular risk factor","volume":"115","author":"Sowers","year":"2003","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib34","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/aje\/kwu007","article-title":"Obesity as a risk factor for sciatica: a meta-analysis","volume":"179","author":"Shiri","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib35","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.disamonth.2017.12.001_bib36","doi-asserted-by":"crossref","first-page":"291546","DOI":"10.1155\/2013\/291546","article-title":"Obesity as a major risk factor for cancer","volume":"2013","author":"De Pergola","year":"2013","journal-title":"J Obes"},{"key":"10.1016\/j.disamonth.2017.12.001_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-319-42542-9_2","article-title":"Obesity and colorectal cancer","volume":"208","author":"Jochem","year":"2016","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"issue":"3 Suppl","key":"10.1016\/j.disamonth.2017.12.001_bib39","first-page":"77","article-title":"Intra-abdominal obesity: an untreated risk factor for type 2 diabetes and cardiovascular disease","volume":"29","author":"Despr\u00e9s","year":"2006","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.gtc.2016.07.012","article-title":"Obesity epidemiology worldwide","volume":"45","author":"Arroyo-Johnson","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jama.2013.91","article-title":"The US health disadvantage relative to other high-income countries: findings from a national research council\/institute of medicine report","volume":"309","author":"Woolf","year":"2013","journal-title":"JAMA"},{"issue":"219","key":"10.1016\/j.disamonth.2017.12.001_bib42","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2011-2014","author":"Ogden","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amepre.2011.10.026","article-title":"Obesity and severe obesity forecasts through 2030","volume":"42","author":"Finkelstein","year":"2012","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2012.40","article-title":"Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010","volume":"307","author":"Ogden","year":"2012","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib45","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/oby.2008.351","article-title":"Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic","volume":"16","author":"Wang","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"24","key":"10.1016\/j.disamonth.2017.12.001_bib46","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.2012.108099","article-title":"Trends in the prevalence of extreme obesity among US preschool-aged children living in low-income families, 1998-2010","volume":"308","author":"Pan","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1542\/peds.2011-1833","article-title":"Decreasing prevalence of obesity among young children in Massachusetts from 2004 to 2008","volume":"129","author":"Wen","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.disamonth.2017.12.001_bib48","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.5888\/pcd9.120118","article-title":"Prevalence, disparities, and trends in obesity and severe obesity among students in the Philadelphia, Pennsylvania, school district, 2006\u20132010","volume":"9","author":"Robbins","year":"2012","journal-title":"Prev Chronic Dis"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib49","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/oby.21497","article-title":"Prevalence of obesity and severe obesity in US children, 1999-2014","volume":"24","author":"Skinner","year":"2016","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMp048029","article-title":"Surgery for severe obesity","volume":"350","author":"Steinbrook","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/17477161003587774","article-title":"Trends and racial\/ethnic disparities in severe obesity among US children and adolescents, 1976\u20132006","volume":"6","author":"Claire Wang","year":"2011","journal-title":"Int J Pediatr Obes"},{"key":"10.1016\/j.disamonth.2017.12.001_bib52","first-page":"1","article-title":"Adult obesity prevalence in Canada and the United States","volume":"56","author":"Shields","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.disamonth.2017.12.001_bib53","first-page":"2009","article-title":"Prevalence of obesity among children and adolescents in the United States and Canada","volume":"211","author":"Carroll","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"Suppl 2","key":"10.1016\/j.disamonth.2017.12.001_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/00333549141291S206","article-title":"The social determinants of health: it\u2019s time to consider the causes of the causes","volume":"129","author":"Braveman","year":"2014","journal-title":"Public Health Rep"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib55","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/sj.ijo.0802716","article-title":"Obesity and inequities in health in the developing world","volume":"28","author":"Monteiro","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl. 3","key":"10.1016\/j.disamonth.2017.12.001_bib56","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.ijo.0802804","article-title":"The nutrition transition: worldwide obesity dynamics and their determinants","volume":"28","author":"Popkin","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"9404","key":"10.1016\/j.disamonth.2017.12.001_bib57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(03)15368-8","article-title":"Physical activity and obesity","volume":"363","author":"Hill","year":"2004","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.disamonth.2017.12.001_bib58","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1111\/j.1467-789X.2007.00329.x","article-title":"Physical activity and obesity","volume":"8","author":"Fox","year":"2007","journal-title":"Obes Rev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib59","unstructured":"{C}Health and Social Care Information Centre. Statistics on obesity, physical activity and diet. 39 pages, 2016. http:\/\/www.digital.nhs.uk\/catalogue\/PUB20562. [Assessed 23 November 2017]."},{"issue":"13","key":"10.1016\/j.disamonth.2017.12.001_bib60","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bjsm.2010.073726","article-title":"Physical activity in the UK: a unique crossroad?","volume":"44","author":"Weiler","year":"2010","journal-title":"Br J Sports Med"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1499-4046(06)60245-5","article-title":"Food advertising in the age of obesity: Content analysis of food advertising on general market and African American television","volume":"37","author":"Henderson","year":"2005","journal-title":"J Nutr Educ Behav"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13679-014-0120-0","article-title":"Changing the food environment for obesity prevention: key gaps and future directions","volume":"3","author":"Anderson","year":"2014","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.disamonth.2017.12.001_bib63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-5868-3-2","article-title":"Are fast food restaurants an environmental risk factor for obesity?","volume":"3","author":"Jeffery","year":"2006","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/09540261.2012.688195","article-title":"The global childhood obesity epidemic and the association between socio-economic status and childhood obesity","volume":"24","author":"Wang","year":"2012","journal-title":"Int Rev Psychiatry"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib65","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/1090198111428646","article-title":"Healthy people: a 2020 vision for the social determinants approach","volume":"38","author":"Koh","year":"2011","journal-title":"Health Educ Behav"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib66","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1542\/peds.68.6.880","article-title":"American Academy of Pediatrics. Committee on Nutrition. Nutritional aspects of obesity in infancy and childhood","volume":"68","author":"No authors listed","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.disamonth.2017.12.001_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/ajhb.23036","article-title":"SDTR. Abdominal obesity in adolescents: development of age-specific waist circumference cut-offs linked to adult IDF criteria","author":"Bravo","year":"2017","journal-title":"Am J Hum Biol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib68","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity--assessment, treatment, and prevention: An endrocrine society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosissup.2008.05.011","article-title":"Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity","volume":"9","author":"Hsieh","year":"2008","journal-title":"Atheroscler Suppl"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib71","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ijo.2016.17","article-title":"Misclassification of cardiometabolic health when using body mass index categories in NHANES 2005\u20132012","volume":"40","author":"Tomiyama","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/nu8060320","article-title":"Does metabolically healthy obesity exist?","volume":"8","author":"Mu\u00f1oz-Garach","year":"2016","journal-title":"Nutrients"},{"issue":"Suppl. 9","key":"10.1016\/j.disamonth.2017.12.001_bib73","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1111\/j.1399-5448.2007.00330.x","article-title":"Clinical presentation and treatment of type 2 diabetes in children","volume":"8","author":"Pinhas-Hamiel","year":"2007","journal-title":"Pediatr Diabetes"},{"issue":"4 Pt 1","key":"10.1016\/j.disamonth.2017.12.001_bib74","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1399-5448.2010.00706.x","article-title":"Onset features and subsequent clinical evolution of childhood diabetes over several years","volume":"12","author":"Lipton","year":"2011","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1824-7288-40-33","article-title":"Syndromic obesity: clinical implications of a correct diagnosis","volume":"40","author":"Milani","year":"2014","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib76","first-page":"839650","article-title":"MOMO syndrome with holoprosencephaly and cryptorchidism: expanding the spectrum of the new obesity syndrome","volume":"2011","author":"Sharda","year":"2011","journal-title":"Case Rep Genet"},{"key":"10.1016\/j.disamonth.2017.12.001_bib77","unstructured":"Syndromes{C}. Genetics Home Reference. https:\/\/ghr.nim.nih.gov. [Assessed 3 December 2017]."},{"key":"10.1016\/j.disamonth.2017.12.001_bib78","unstructured":"Hamdy{C} O. Obesity Work-up Published on Line with Medscape Internet. Updated Oct. 11, 2017."},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib79","first-page":"6","article-title":"Pediatric obesity and cardiometabolic disorders: risk factors and biomarkers","volume":"28","author":"Levy","year":"2017","journal-title":"EJIFCC"},{"key":"10.1016\/j.disamonth.2017.12.001_bib80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4291\/wjgp.v8.i2.11","article-title":"Nonalcoholic fatty liver disease: diagnostic biomarkers","volume":"8","author":"Hadizadeh","year":"2017","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib81","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2431-14-81","article-title":"Abdominal obesity and serum adiponectin complexes among population-based elementary school children in Japan: a cross-sectional study","volume":"14","author":"Ochiai","year":"2014","journal-title":"BMC Pediatr"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib82","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MPG.0b013e31817fcb67","article-title":"Adiponectin and insulin resistance in childhood obesity","volume":"47","author":"Panagopoulou","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib83","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00247-009-1247-0","article-title":"Pediatric body composition analysis with dual-energy X-ray absorptiometry","volume":"39","author":"Helba","year":"2009","journal-title":"Pediatr Radiol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib84","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1148\/rg.2016150198","article-title":"Bariatric CT imaging: challenges and solutions","volume":"36","author":"Fursevich","year":"2016","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib85","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00431-008-0789-8","article-title":"Assessment of the medial longitudinal arch in children and adolescents with obesity: footprints and radiographic study","volume":"168","author":"Villarroya","year":"2009","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib86","doi-asserted-by":"crossref","first-page":"A18","DOI":"10.1016\/j.clinthera.2012.12.014","article-title":"Childhood obesity: a review of increased risk for physical and psychological comorbidities","volume":"35","author":"Pulgar\u00f3n","year":"2013","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/obr.12316","article-title":"Childhood obesity as a predictor of morbidity in adulthood: a systematic review and meta-analysis","volume":"17","author":"Llewellyn","year":"2016","journal-title":"Obes Rev"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib88","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00431-017-2931-y","article-title":"The psychosocial burden of childhood overweight and obesity: evidence for persisting difficulties in boys and girls","volume":"176","author":"Gibson","year":"2017","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib89","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/0165025416647799","article-title":"Overweight and isolated: The interpersonal problems of youth who are overweight from adolescence into young adulthood","volume":"41","author":"Ames","year":"2017","journal-title":"Int J Behav Dev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib90","first-page":"1443","volume":"18","author":"S\u00e1nchez-Villegas","year":"2010"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib91","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00127-015-1101-7","article-title":"Adiposity and psychosocial outcomes at ages 30 and 35","volume":"51","author":"McLeod","year":"2016","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib92","doi-asserted-by":"crossref","first-page":"e11896","DOI":"10.1371\/journal.pone.0011896","article-title":"Prenatal stress exposure related to maternal bereavement and risk of childhood overweight","volume":"5","author":"Li","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.disamonth.2017.12.001_bib93","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.appet.2016.04.042","article-title":"The influence of maternal psychosocial characteristics on infant feeding styles","volume":"103","author":"Barrett","year":"2016","journal-title":"Appetite"},{"key":"10.1016\/j.disamonth.2017.12.001_bib94","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpeds.2016.06.023","article-title":"Body mass index at 3 years of age: cascading effects of prenatal maternal depression and mother-infant dynamics","volume":"177","author":"Braungart-Rieker","year":"2016","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib95","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jada.2011.06.010","article-title":"Parenting style and child feeding practices: potential mitigating factors in the etiology of childhood obesity","volume":"111","author":"Stang","year":"2011","journal-title":"J Am Diet Assoc"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib96","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/chi.2012.0135","article-title":"Maternal psychological factors and controlled child feeding practices in relation to child body mass index","volume":"9","author":"Gemmill","year":"2013","journal-title":"Child Obes"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib97","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/smi.2501","article-title":"Stress and paediatric obesity: what we know and where to go","volume":"30","author":"Wilson","year":"2014","journal-title":"Stress Health"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib98","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ssresearch.2009.06.002","article-title":"Family stressors and child obesity","volume":"38","author":"Garasky","year":"2009","journal-title":"Soc Sci Res"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib99","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1467-789x.2001.00027.x","article-title":"Do stress reactions cause abdominal obesity and comorbidities?","volume":"2","author":"Bj\u00f6rntorp","year":"2001","journal-title":"Obes Rev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib100","doi-asserted-by":"crossref","DOI":"10.1007\/s10826-017-0811-8","article-title":"Children exposed to marital conflict exhibit more disordered eating behaviors: Child emotional insecurity and anxiety as mechanisms of risk","author":"Bi","year":"2017","journal-title":"J Child Fam Stud"},{"key":"10.1016\/j.disamonth.2017.12.001_bib101","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.appet.2016.02.026","article-title":"Does child temperament modify the overweight risk associated with parent feeding behaviors and child eating behaviors?: An exploratory study","volume":"101","author":"Tate","year":"2016","journal-title":"Appetite"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10995-010-0601-z","article-title":"Dalton WT 3rd, et al. Joint effects of child temperament and maternal sensitivity on the development of childhood obesity","volume":"15","author":"Wu","year":"2011","journal-title":"Matern Child Health J"},{"issue":"Suppl","key":"10.1016\/j.disamonth.2017.12.001_bib103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/17477166.2011.615996","article-title":"Stress and obesity\/metabolic syndrome in childhood and adolescence","volume":"1","author":"Pervanidou","year":"2011","journal-title":"Int J Pediatr Obes"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib104","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/DBP.0b013e3182a509c0","article-title":"Social and behavioral risk factors for obesity in early childhood","volume":"34","author":"Suglia","year":"2013","journal-title":"J Dev Behav Pediatr"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib105","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/obr.12216","article-title":"Effects of childhood abuse on adult obesity: a systematic review and meta-analysis","volume":"15","author":"Hemmingsson","year":"2014","journal-title":"Obes Rev"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib106","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ijo.2014.19","article-title":"Obesity and depression in adolescence and beyond: reciprocal risks","volume":"38","author":"Marmorstein","year":"2014","journal-title":"Int J Obes"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib107","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1037\/hea0000496","article-title":"Symptoms of stress and depression effect percentage of body fat and insulin resistance in healthy youth: LOOK longitudinal study","volume":"36","author":"Olive","year":"2017","journal-title":"Health Psychol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.appet.2016.07.022","article-title":"Impulsivity, perceived self-regulatory success in dieting, and body mass in children and adolescents: a moderated mediation model","volume":"107","author":"Meule","year":"2016","journal-title":"Appetite"},{"issue":"Suppl 2","key":"10.1016\/j.disamonth.2017.12.001_bib109","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/ijo.2009.72","article-title":"Psychobiological traits in the risk profile for overeating and weight gain","volume":"33","author":"Davis","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib110","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.pcl.2011.09.008","article-title":"Psychological complications of pediatric obesity","volume":"58","author":"Vander Wal","year":"2011","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib111","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1037\/0033-2909.133.4.557","article-title":"Stigma, obesity, and the health of the nation\u2019s children","volume":"133","author":"Puhl","year":"2007","journal-title":"Psychol Bull"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/oby.20092","article-title":"Weight-related teasing from adolescence to young adulthood: Longitudinal and secular trends between 1999 and 2010","volume":"21","author":"Haines","year":"2013","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib113","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/cdev.12548","article-title":"The social and emotional lives of overweight, obese, and severely obese children","volume":"87","author":"Harrist","year":"2016","journal-title":"Child Dev"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib114","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.2047-6310.2012.00078.x","article-title":"Teasing, depression and unhealthy weight control behaviour in obese children","volume":"7","author":"Madowitz","year":"2012","journal-title":"Pediatr Obes"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/000992280504400103","article-title":"Peer victimization and psychosocial adjustment in children: current knowledge and future directions","volume":"44","author":"Storch","year":"2005","journal-title":"Clin Pediatr"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib116","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archpedi.157.8.733","article-title":"Associations of weight-based teasing and emotional well-being among adolescents","volume":"157","author":"Eisenberg","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib117","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1542\/peds.2006-0511","article-title":"Obesity and risk of low self-esteem: a statewide survey of Australian children","volume":"118","author":"Franklin","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib118","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/00048670701787560","article-title":"Clustering of psychosocial symptoms in overweight children","volume":"42","author":"Gibson","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.disamonth.2017.12.001_bib119","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/AHMT.S101631","article-title":"Psychological consequences of childhood obesity: psychiatric comorbidity and prevention","volume":"7","author":"Rankin","year":"2016","journal-title":"Adolesc Health Med Ther"},{"key":"10.1016\/j.disamonth.2017.12.001_bib120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.adolescence.2015.08.014","article-title":"Adolescent obesity and future substance use: incorporating the psychosocial context","volume":"45","author":"Lanza","year":"2015","journal-title":"J Adolesc"},{"key":"10.1016\/j.disamonth.2017.12.001_bib121","series-title":"Obesity and Adolescence: A Public Health Concern","author":"Omar","year":"2009"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib122","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2106\/JBJS.J.01839","article-title":"Effects of obesity on pediatric care and management","volume":"94","author":"Lazar-Antman","year":"2012","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib123","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman's long- term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib126","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000375530","article-title":"The diagnosis of polycystic ovary syndrome during adolescence. hormone research in paediatrics","volume":"83","author":"Witchel","year":"2015","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib127","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/GCO.0000000000000301","article-title":"Polycystic ovary syndrome in adolescents: a review of past year evidence","volume":"28","author":"Javed","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.disamonth.2017.12.001_bib128","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib130","series-title":"Polycystic Ovary Syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib132","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib133","unstructured":"National Institutes of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome December 3\u20135, 2012. 2012."},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2010.06.015","article-title":"Polycystic ovarian morphology in postmenarchal adolescents","volume":"95","author":"Codner","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.disamonth.2017.12.001_bib135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1429.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"1135","author":"Blank","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.disamonth.2017.12.001_bib136","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11154-013-9243-y","article-title":"Revisiting hyper- and hypo-androgenism by tandem mass spectrometry","volume":"14","author":"Fanelli","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.disamonth.2017.12.001_bib137","first-page":"e4","article-title":"Polycystic ovarian syndrome: a diagnostic and therapeutic challenge","volume":"2","author":"Kamboj","year":"2010","journal-title":"J Pediatric Sci"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib138","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"Bremer","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib139","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"34","author":"Buggs","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jpag.2015.01.002","article-title":"Effect of dietary weight loss on menstrual regularity in obese young adult women with polycystic ovary syndrome","volume":"28","author":"Marzouk","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib141","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jamapediatrics.2015.4866","article-title":"Treatment considerations for the cardiometabolic signs of polycystic ovary syndrome: a review of the literature since the 2013 endocrine society clinical practice guidelines","volume":"170","author":"Fields","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib142","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1210\/jc.2011-1609","article-title":"Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls","volume":"96","author":"Lass","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib143","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib144","doi-asserted-by":"crossref","first-page":"e20154089","DOI":"10.1542\/peds.2015-4089","article-title":"Metformin or oral contraceptives for adolescents with polycystic ovarian xyndrome: a meta-analysis","volume":"137","author":"Al Khalifah","year":"2016","journal-title":"Pediatrics"},{"issue":"24","key":"10.1016\/j.disamonth.2017.12.001_bib145","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/jama.297.24.2716","article-title":"Dabelea D, Bell RA, D'Agostino RB Jr, et al. Incidence of diabetes in youth in the United States","volume":"297","author":"Writing Group for the SEARCH for Diabetes in Youth Study Group","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib146","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mpd.2000.105141","article-title":"Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective","volume":"136","author":"Fagot-Campagna","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib147","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Estimates of diabetes and its burden in the United States. Atlanta, CA. https:\/\/www.cdc.gov\/diabetes\/pdfs\/data\/statistics\/national-diabetes-statistics-report.pdf. [Accessed 23 November 17]."},{"issue":"Suppl 1","key":"10.1016\/j.disamonth.2017.12.001_bib148","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc17-S005","article-title":"Classification and diagnosis of diabetes","volume":"40","author":"American Diabetes Association","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib149","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1210\/jc.2016-2574","article-title":"Treatment of pediatric obesity: an umbrella systematic review","volume":"102","author":"Rajjo","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40169-016-0099-0","article-title":"Researchers\u2019 Perspectives on pediatric obesity research participant recruitment","volume":"5","author":"Parikh","year":"2016","journal-title":"Clin Transl Med"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib151","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.beem.2005.04.010","article-title":"Childhood obesity. Treatment options","volume":"19","author":"Steinbeck","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib152","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3476(85)80506-0","article-title":"Effect of diet and controlled exercise on weight loss in obese children","volume":"107","author":"Epstein","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib153","first-page":"1","article-title":"Obesity. preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","author":"No authors listed","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"Suppl. 2","key":"10.1016\/j.disamonth.2017.12.001_bib154","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1542\/peds.2011-0480D","article-title":"Assessment of obese children and adolescents: a survey of pediatric obesity- management programs","volume":"128","author":"Eisenmann","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.disamonth.2017.12.001_bib155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13063-016-1161-3","article-title":"Effectiveness of a behavioral incentive scheme linked to goal achievement: study protocol for a randomised controlled trial","volume":"17","author":"Redfern","year":"2016","journal-title":"Trial"},{"key":"10.1016\/j.disamonth.2017.12.001_bib156","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2431-12-39","article-title":"A shared-care model of obesity treatment for 3- 10 year old children: protocol for the HopSCOTCH randomized controlled trial","volume":"12","author":"Wake","year":"2012","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib157","doi-asserted-by":"crossref","first-page":"f3092","DOI":"10.1136\/bmj.f3092","article-title":"Shared care obesity mangement in 3 -10 year old children: 12 month outcomes of HopSCOTCH randomized trial","volume":"346","author":"Wake","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.disamonth.2017.12.001_bib158","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1745-6215-12-242","article-title":"Assessing the efficacy of the healthy eating and lifestyle programme (HELP) compared with enhanced standard care of the obese adolescent in the community: study protocol for a randomized controlled trial","volume":"12","author":"Christie","year":"2011","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib159","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/archdischild-2016-311586","article-title":"A community-based motivational personalized lifestyle intervention to reduce BMI in obese adolescents: results from the health eating and lifestyle programme (HELP) randomized controlled trial","volume":"102","author":"Christie","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.disamonth.2017.12.001_bib160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2431-14-215","article-title":"Study protocol: effects of the THAO-child health intervention program on the prevention of childhood obesity \u2013 The POIBC study","volume":"14","author":"Gomez","year":"2014","journal-title":"BMC Pediatr"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib161","first-page":"2584","article-title":"ThaO-Child Health Programme: community- based interventions for healthy lifestyles promotion to children and families: results of a cohort study","volume":"32","author":"Santiago","year":"2015","journal-title":"Nutr Hosp"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib162","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11154-013-9261-9","article-title":"Brain regulation of energy balance and body weight","volume":"14","author":"Rui","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib163","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.psc.2011.08.008","article-title":"Regulation of energy balance and body weight by the brain: a distributed system prone to disruption","volume":"34","author":"Faulconbridge","year":"2011","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.disamonth.2017.12.001_bib164","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1515\/JPEM.2004.17.3.307","article-title":"Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions","volume":"17","author":"McDuffie","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib165","first-page":"1","article-title":"The benefits of sports participation in childhood and adolescence to prevent obesity in adolescents and adults","volume":"9","author":"Greydanus","year":"2006","journal-title":"Asian J Paediatric Practice"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib166","first-page":"545","article-title":"Obesity in the adolescent","volume":"41","author":"Greydanus","year":"2004","journal-title":"Indian Pediatrics"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib167","first-page":"385","article-title":"Pharmacology for Obese Adolescents","volume":"1","author":"Greydanus","year":"2008","journal-title":"Int J Child and Human Development"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib168","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pcl.2010.10.007","article-title":"Pharmacology for Obese Adolescents","volume":"58","author":"Greydanus","year":"2011","journal-title":"Pediatric Clin No Amer"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib169","first-page":"576","article-title":"Weight loss medications\u2014where do they fit in?","volume":"35","author":"Dixon","year":"2006","journal-title":"Aust Fam Physician"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11906-013-0343-6","article-title":"Pharmacologic treatment options for obesity: what is old is new again","volume":"15","author":"Ryan","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib171","first-page":"18","article-title":"Obesity epidemic: pharmaceutical weight loss","volume":"100","author":"Curry","year":"2017","journal-title":"R I Med J (2013)"},{"issue":"5 Suppl. 1","key":"10.1016\/j.disamonth.2017.12.001_bib172","article-title":"Pediatric obesity epidemic: treatment options","volume":"105","author":"Kirk","year":"2005","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.disamonth.2017.12.001_bib173","first-page":"191","article-title":"\u201cManaging the overweight child\u201d","volume":"vol. 2","author":"Eneli","year":"2008"},{"key":"10.1016\/j.disamonth.2017.12.001_bib174","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/adc.2006.098962","article-title":"Should metformin be prescribed to overweight adolescents in whom dietary\/behavioural modifications have not helped?","volume":"91","author":"Webb","year":"2006","journal-title":"Arch Dis Child"},{"issue":"6926","key":"10.1016\/j.disamonth.2017.12.001_bib175","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/bmj.308.6926.430","article-title":"The European Medicines Evaluation Agency","volume":"308","author":"Bosanquet","year":"1994","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib176","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jval.2014.04.006","article-title":"Improving the contribution of regulatory assessment reports to health technology assessments\u2014a collaboration between European Medicines Agency and the European network for Health Technology Assessment","volume":"17","author":"Berntgen","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.disamonth.2017.12.001_bib177","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/DMSO.S95299","article-title":"Off-label drugs for weight management","volume":"10","author":"Hendricks","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"14","key":"10.1016\/j.disamonth.2017.12.001_bib178","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1517\/14656566.2014.946904","article-title":"Overview of new antiobesity drugs","volume":"15","author":"Hainer","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.disamonth.2017.12.001_bib179","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-017-0719-6","article-title":"Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options","author":"Verhaegen","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.disamonth.2017.12.001_bib180","doi-asserted-by":"crossref","unstructured":"Wilding JPH. Medication use for the treatment of diabetes in obese individuals. Diabetologia May. http:\/\/dx.doi.org\/10.1007\/s00125-017-4288-1.","DOI":"10.1007\/s00125-017-4288-1"},{"key":"10.1016\/j.disamonth.2017.12.001_bib181","series-title":"Clinical Aspects of Psychopharmacology in Childhood and Adolescence","year":"2017"},{"key":"10.1016\/j.disamonth.2017.12.001_bib182","doi-asserted-by":"crossref","unstructured":"Rodr\u00edquez JE, Campbell KM. Past, present and future of pharmacologic therapy in obesity. Prim Care 2016;43(1):61-67.","DOI":"10.1016\/j.pop.2015.08.011"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib183","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0884533617713189","article-title":"Epidemiology of obesity and pharmacologic treatment options","volume":"32","author":"Shettar","year":"2017","journal-title":"Nutr Clin Pract"},{"issue":"1089","key":"10.1016\/j.disamonth.2017.12.001_bib184","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/postgradmedj-2015-133388","article-title":"Drugs to treat obesity: do they work?","volume":"92","author":"Kim","year":"2016","journal-title":"Postgrad Med J"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib185","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMra012586","article-title":"Obesity","volume":"346","author":"Yanovski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2017.12.001_bib186","first-page":"11","article-title":"Drug interventions for the treatment of obesity in children and adolescents","author":"Mead","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib187","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2165\/00003495-199243060-00003","article-title":"Appetite suppressants. A review","volume":"43","author":"Silverstone","year":"1992","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib188","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cob.12101","article-title":"Adolescent experiences of anti-obesity drugs","volume":"5","author":"White","year":"2015","journal-title":"Clin Obes"},{"issue":"Suppl. 4","key":"10.1016\/j.disamonth.2017.12.001_bib189","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report","volume":"120","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.disamonth.2017.12.001_bib190","article-title":"Pharmacological management of obesity","author":"Velazquez","year":"2017","journal-title":"Minerva Endocrinol"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib191","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2146\/ajhp140034","article-title":"Past and present antiobesity agents: focus on monoamine modulators","volume":"72","author":"Khorassani","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib192","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ecl.2016.04.005","article-title":"Pharmacotherapy for obesity","volume":"45","author":"Saunders","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib193","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ncpgasthep0092","article-title":"Drug insight: appetite suppressants","volume":"2","author":"Bray","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib194","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/092986709787315568","article-title":"Obesity: pathophysiology and clinical management","volume":"16","author":"Gurevich-Panigraphi","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.disamonth.2017.12.001_bib195","first-page":"698","article-title":"Current therapeutics. 203. Sustained-action chlorphentermine in the correction of refractory obesity","volume":"193","author":"Seaton","year":"1964","journal-title":"Practitioner"},{"key":"10.1016\/j.disamonth.2017.12.001_bib196","unstructured":"No authors listed. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon? Prescrire Int. 2012 Sep;21(130):209."},{"key":"10.1016\/j.disamonth.2017.12.001_bib197","doi-asserted-by":"crossref","first-page":"179674","DOI":"10.1155\/2011\/179674","article-title":"Pharmacotherapies for obesity: past, current and future therapies","volume":"2011","author":"Ioannides-Demos","year":"2011","journal-title":"J Obes"},{"issue":"12","key":"10.1016\/j.disamonth.2017.12.001_bib198","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/phar.1342","article-title":"Use of prescription antiobesity drugs in the United States","volume":"33","author":"Hampp","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib199","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/dom.12502","article-title":"Current and emerging medications for overweight or obesity in people with comorbidities","volume":"17","author":"Fujioka","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib200","first-page":"2702","article-title":"Treatment of obesity with a new anorexiant, diethylpropion, without special stress on diet","volume":"60","author":"Decina","year":"1960","journal-title":"N Y State J Med"},{"key":"10.1016\/j.disamonth.2017.12.001_bib201","unstructured":"No Authors listed. Diethylpropion, an appetite suppressant. Med Lett Drugs Ther 1971;12(25):101-2."},{"issue":"Suppl 5","key":"10.1016\/j.disamonth.2017.12.001_bib202","first-page":"121","article-title":"Update on pharmacology of obesity: benefits and risks","volume":"28","author":"Cabrerizo Garcia","year":"2013","journal-title":"Nutr Hosp"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib203","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.pbb.2008.10.001","article-title":"Diethylpropion produces psychostimulant and reward effects","volume":"91","author":"Garcia-Mijares","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1590\/1806-9282.63.03.203","article-title":"Diethylpropion and mazindol: an end to the discussion?","volume":"63","author":"Lucchetta","year":"2017","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.disamonth.2017.12.001_bib205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.appet.2016.01.036","article-title":"The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction","volume":"100","author":"Kalyanasundar","year":"2016","journal-title":"Appetite"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib206","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ijo.2009.124","article-title":"A randomized double-blind placebo-controlled study of the long term efficacy and safety of diethylpropion in the treatment of obese subjects","volume":"33","author":"Cercato","year":"2009","journal-title":"Int J Obes"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib207","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5414\/CP202135","article-title":"Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized controlled trail","volume":"53","author":"Soto-Molina","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.disamonth.2017.12.001_bib208","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0074-7742(09)88009-4","article-title":"Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion","volume":"88","author":"Arias","year":"2009","journal-title":"Int Rev Neurobiol"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib209","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ijo.2013.225","article-title":"A comparative study of five centrally acting drugs on the pharmacologic treatment of obesity","volume":"38","author":"Suplicy","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.disamonth.2017.12.001_bib210","article-title":"Heritable pulmonary arterial hypertension. GeneReviews [Internet]. Seattle (WA): University of Washington","author":"Austin","year":"2002","journal-title":"Seattle; 1993-2017"},{"key":"10.1016\/j.disamonth.2017.12.001_bib211","doi-asserted-by":"crossref","unstructured":"No authors listed. Diethylpropion psychosis. Med J Aust 1970;2(23):1052-1053.","DOI":"10.5694\/j.1326-5377.1970.tb63346.x"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib212","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-198804000-00011","article-title":"Diethylpropion and psychosis","volume":"11","author":"Carney","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib213","first-page":"33","article-title":"A controlled clinical trial of benzphetamine (didrex) in the management of obesity","volume":"2","author":"Simkin","year":"1960","journal-title":"Curr Ther Res Clin Exp"},{"issue":"7-8","key":"10.1016\/j.disamonth.2017.12.001_bib214","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/dta.1570","article-title":"New phenethylamines in Europe","volume":"6","author":"King","year":"2014","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.disamonth.2017.12.001_bib215","first-page":"62","article-title":"Phenmetrazine in the treatment of obesity","volume":"183","author":"Phear","year":"1959","journal-title":"Practitioner"},{"key":"10.1016\/j.disamonth.2017.12.001_bib216","first-page":"354","article-title":"Appetite suppressant drugs: a controlled clinical comparison of benzphetamine, phenmetrazine, d-amphetamine and placebo","volume":"2","author":"Poindexter","year":"1960","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.disamonth.2017.12.001_bib217","first-page":"1114","article-title":"Evaluation of phenmetrazine bitartrate as an appetite suppressant","volume":"84","author":"Cass","year":"1961","journal-title":"Can Med Assoc J"},{"issue":"7095","key":"10.1016\/j.disamonth.2017.12.001_bib218","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(59)90562-8","article-title":"Psychosis and addiction to phenmetrazine (preludin)","volume":"2","author":"Evans","year":"1959","journal-title":"Lancet"},{"issue":"3-4","key":"10.1016\/j.disamonth.2017.12.001_bib219","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/15563658809000351","article-title":"Fatality from illicit phendimetrazine use","volume":"26","author":"Hood","year":"1988","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1757-1626-1-105","article-title":"A case of demand ischemia from phendimetrazine","volume":"1","author":"Landau","year":"2008","journal-title":"Cases J"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib221","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1060028014557859","article-title":"Pharmacological management of obesity in pediatric patients","volume":"49","author":"Boland","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.disamonth.2017.12.001_bib222","first-page":"35","article-title":"Management of obesity and cardiometabolic risk \u2013 role of phentermine\/extended release topiramate","volume":"7","author":"Sweeting","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib223","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib224","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14740338.2017.1247807","article-title":"Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone\/ bupropion and phentermine-topiramate extended release","volume":"16","author":"Halpern","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"10.1016\/j.disamonth.2017.12.001_bib225","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1586\/erc.10.125","article-title":"Phentermine, topiramate and their combination for the treatment of adiposopathy (\u2018sick fat\u2019) and metabolic disease","volume":"8","author":"Bays","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib226","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40264-014-0206-3","article-title":"Tolerability and safety of the new anti-obesity medications","volume":"37","author":"Hainer","year":"2014","journal-title":"Drug Saf"},{"issue":"Suppl 1","key":"10.1016\/j.disamonth.2017.12.001_bib227","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/oby.21093","article-title":"Efficacy comparison of medications approved for chronic weight management","volume":"23","author":"Kumar","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"22","key":"10.1016\/j.disamonth.2017.12.001_bib228","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse effects: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib229","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1060028016634351","article-title":"A comparison of new pharmacological agents for the treatment of obesity","volume":"50","author":"Nuffer","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CRD.0000000000000001","article-title":"obesity agents: lorcaserin (Belviq) and phentermine\/ topiramate ER (Qsymia)","volume":"22","author":"Shyh","year":"2014","journal-title":"Cardio Rev"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib231","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/clc.22304","article-title":"Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit","volume":"37","author":"Cunningham","year":"2014","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib232","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2337\/dc17-0088","article-title":"Cardiometabolic disease predicts effectiveness of weight-loss therapy to prevent type 2 diabetes: pooled results from Phase III clinical trials assessing phentermine\/topiramate extended release","volume":"40","author":"Guo","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.disamonth.2017.12.001_bib233","doi-asserted-by":"crossref","DOI":"10.2174\/1381612823666170608083343","article-title":"Obesity-induced hypertension: new insights","author":"Antza","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.disamonth.2017.12.001_bib234","unstructured":"No authors listed. Topiramate + phentermine. An excessively dangerous appetite-suppressant combination. Prescrire Int 2013;22(136):61-64."},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib235","doi-asserted-by":"crossref","first-page":"642","DOI":"10.18553\/jmcp.2013.19.8.642","article-title":"Formulary management of 2 new agents: lorcaserin and phentermine\/topiramate for weight loss","volume":"19","author":"Kelly","year":"2013","journal-title":"J Manag Care Pharm"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib236","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamainternmed.2013.14629","article-title":"The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?","volume":"174","author":"Woloshin","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib237","first-page":"831","article-title":"Drug safety evaluation of naltrexone\/bupropion for the treatment of obesity","volume":"13","author":"Verpeut","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.disamonth.2017.12.001_bib238","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s11095-009-9961-8","article-title":"The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance protein","volume":"26","author":"Luna-Tort\u00f3s","year":"2009","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib239","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/cn200076y","article-title":"ACS chemical neuroscience molecule spotlight on contrave","volume":"2","author":"Mercer","year":"2011","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.disamonth.2017.12.001_bib240","unstructured":"No authors listed. Contrave\u2014a combination of bupropion and naltrexone for weight loss. Med Lett Drugs Ther 2014;56(1455):112-114."},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib241","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/17512433.2016.1100072","article-title":"Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity","volume":"9","author":"Ali","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib242","first-page":"1117","article-title":"Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity","volume":"10","author":"Padwal","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.disamonth.2017.12.001_bib243","doi-asserted-by":"crossref","unstructured":"No authors listed. Naltrexone\/bupropion: Contrave (R): naltrexone SR\/bupropion SR. Drugs R D 2010;10(1):25-32.","DOI":"10.2165\/11537710-000000000-00000"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib244","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity (Silver Springs)"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib245","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s40265-015-0427-5","article-title":"Naltrexone ER\/Bupropion ER: a review in obesity management","volume":"75","author":"Greig","year":"2015","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.disamonth.2017.12.001_bib246","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.2015.1617","article-title":"Naltrexone extended-release plus bupropion extended-release for treatment of obesity","volume":"313","author":"Yanovski","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2017.12.001_bib247","doi-asserted-by":"crossref","unstructured":"O\u2019Neil PM, Smith SR, Weissman NJ, et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring) 20(7):1426-36.","DOI":"10.1038\/oby.2012.66"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib248","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/17425255.2013.798643","article-title":"Evaluation of lorcaserin for the treatment of obesity","volume":"9","author":"Berlie","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib249","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2017.06.004","article-title":"Lorcaserin plus lifestyle modification for weight loss maintenance: rationale and design for a randomized controlled trial","volume":"59","author":"Tronieri","year":"2017","journal-title":"Contemp Clin Trials"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib250","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/17425255.2017.1344214","article-title":"Pharmacokinetic drug evaluation of extended release lorcaserin for the treatment of obesity","volume":"13","author":"Hurren","year":"2017","journal-title":"Expert Opin Drug Metabb Toxicol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib251","unstructured":"No authors listed. Two drugs for weight loss. Med Lett Dr Ther 2012; 54(1398):69-71."},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib252","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1185\/03007995.2013.794776","article-title":"Lorcaserin: a novel serotonin 2C agonist for the treatment of obesity","volume":"29","author":"Nigro","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib253","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2014.10.2817","article-title":"Safety and efficacy of lorcaserin: a combined analysis of the BLOOM and BLOSSOM trials","volume":"126","author":"Aronne","year":"2014","journal-title":"Postgrad Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib254","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cob.12159","article-title":"Safety and tolerability review of lorcaserin in clinical trials","volume":"6","author":"Greenway","year":"2016","journal-title":"Clin Obes"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib255","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/oby.21811","article-title":"Coadministration of lorcaserin and phentermine for weight management: a 12-week, randomized, pilot safety study","volume":"25","author":"Smith","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.disamonth.2017.12.001_bib256","doi-asserted-by":"crossref","unstructured":"Mehta A, Marso SP, Neeland IJ. Liraglutide for weight management: a critical review of the evidence. Obes Sci Pract 2017;3(1):3-14.","DOI":"10.1002\/osp4.84"},{"key":"10.1016\/j.disamonth.2017.12.001_bib257","unstructured":"Konstantinos L, Karavis M, Mastorakos G, et al. New molecular targets for the pharmacotherapy of obesity. Editors: De Groot LJ, Chrousos G, Dungan K, Feinfold KR, Grossman A, Hershman JM, et al. Endotext (internet). South Dartmouth (MA): MDText.com, Inc; 2000-2015 Apr 8."},{"key":"10.1016\/j.disamonth.2017.12.001_bib258","doi-asserted-by":"crossref","unstructured":"Prasad-Reddy L, Isaacs D. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context 2015 Jul 9:212283. http:dx.doi.org\/10.7573\/dic.212283.","DOI":"10.7573\/dic.212283"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib259","first-page":"71","article-title":"How to fight obesity with antidiabetic drugs: targeting gut or kidney?","volume":"40","author":"Bareti","year":"2015","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib260","doi-asserted-by":"crossref","unstructured":"Hocking S, Dear A, Cowley MA. Current and emerging pharmacotherapies in Australia. Obes Res Clin Pract 2017 Aug 14. pii: S1871-403X(17)30065-0. http:\/\/dx.doi.org\/10.1016\/j.orcp.2017.07.002.","DOI":"10.1016\/j.orcp.2017.07.002"},{"key":"10.1016\/j.disamonth.2017.12.001_bib261","series-title":"Medicine","first-page":"651","article-title":"\u201cObesity in the adolescent\u201d","author":"Rowlett","year":"2006"},{"key":"10.1016\/j.disamonth.2017.12.001_bib262","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.281.3.235","article-title":"Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: A randomized trial","volume":"281","author":"Davidson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2017.12.001_bib263","unstructured":"Orlistat for obesity. Med Lett Drugs Ther;1999. 41:55."},{"issue":"Suppl. 1","key":"10.1016\/j.disamonth.2017.12.001_bib264","first-page":"S168","article-title":"Anti-obesity medication use in adolescents: risks and benefits","volume":"2","author":"Freemark","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-142-7-200504050-00011","article-title":"Pharmacologic and surgical management of obesity in primary care: A clinical practice guideline from the American College of Physicians","volume":"142","author":"Snow","year":"2005","journal-title":"Ann Intern Med"},{"issue":"23","key":"10.1016\/j.disamonth.2017.12.001_bib266","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1001\/jama.293.23.2873","article-title":"Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial","volume":"293","author":"Chanoine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2017.12.001_bib267","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1345\/aph.1K022","article-title":"Pharmacotherapeutic options for overweight adolescents","volume":"41","author":"Dunican","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.disamonth.2017.12.001_bib268","unstructured":"Orlistat OTC for weight loss. Med Lett Drugs Ther 2007; 49:49."},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib269","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/oby.2007.100","article-title":"Are non-prescription medications needed for weight control?","volume":"16","author":"Bray","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib270","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1345\/aph.1H234","article-title":"Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial","volume":"40","author":"Anderson","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.disamonth.2017.12.001_bib271","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP.12.1.18","article-title":"Randomized, double-blind, placebo- controlled trial of orlistat for weight loss in adolescents","volume":"12","author":"Maahs","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1016\/j.disamonth.2017.12.001_bib272","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/TCRM.S124621","article-title":"Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients","volume":"13","author":"Ali Khan","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"10.1016\/j.disamonth.2017.12.001_bib273","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00431-004-1534-6","article-title":"Addition of orlistat to conventional treatment in adolescents with severe obesity","volume":"163","author":"Ozkan","year":"2004","journal-title":"European J Pediatr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib274","doi-asserted-by":"crossref","first-page":"f2777","DOI":"10.1136\/bmj.f2777","article-title":"Orlistat: should we worry about liver inflammation?","volume":"346","author":"Wilding","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib275","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cob.12075","article-title":"Orlistat-induced fulminant hepatic failure","volume":"4","author":"Sali","year":"2014","journal-title":"Clin Obes"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib276","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.diabet.2015.08.006","article-title":"Weight loss at a high cost: Orlistat-induced late-onset severe kidney disease","volume":"42","author":"Buysschaert","year":"2016","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib277","first-page":"124604","article-title":"Acute oxalate nephropathy associated with orlistat: a case report with a review of the literature","volume":"2013","author":"Chaudhari","year":"2013","journal-title":"Case Rep Nephrol"},{"issue":"Suppl. 4","key":"10.1016\/j.disamonth.2017.12.001_bib278","article-title":"Orlistat, an under-recognized cause of progressive renal impairment","volume":"28","author":"Coutinho","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib279","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7861\/clinmedicine.12-5-456","article-title":"Recent advancements in drug treatment of obesty","volume":"12","author":"Carter","year":"2012","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2042098613489721","article-title":"Safety of antiobesity drugs","volume":"4","author":"Cheung","year":"2013","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib281","first-page":"406","article-title":"Management of type 2 diabetes and prediabetes in children and adolescents","volume":"28","author":"Fleischman","year":"2017","journal-title":"Adolesc Med"},{"issue":"Suppl. 1","key":"10.1016\/j.disamonth.2017.12.001_bib282","first-page":"S2","article-title":"Acarbose, a reliable therapeutic principle. [Article in German]","volume":"98","author":"Laube","year":"2003","journal-title":"Med Klin (Munich)"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib283","doi-asserted-by":"crossref","first-page":"832","DOI":"10.18549\/PharmPract.2016.04.832","article-title":"Effects of the addition of acarbose to insulin and non-insulin regimens with type 2 diabetes mellitus","volume":"14","author":"Wettergreen","year":"2016","journal-title":"Pharm Pract"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib284","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40261-013-0063-3","article-title":"A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study","volume":"3","author":"Zhang","year":"2013","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.disamonth.2017.12.001_bib285","first-page":"9","article-title":"Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control","author":"Vos","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib286","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-8587(13)70021-4","article-title":"Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomized trial","volume":"2","author":"Yang","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib287","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126704","article-title":"Comparison of glucose lowering effect of meformin and acarbose in type 2 diabetes mellitus: a meta-analysis","volume":"10","author":"Gu","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib288","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0034-1375676","article-title":"Effects of acarbose on polycystic ovary syndrome: a meta-analysis","volume":"122","author":"Zhang","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib289","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.clinthera.2012.04.012","article-title":"Efficacy and safety profile evaluation of acarbose along and in association with other antidiabetic drugs: a systematic review","volume":"34","author":"Derosa","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.disamonth.2017.12.001_bib290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12986-015-0048-8","article-title":"Review: miglitol has potential as a therapeutic drug against obesity","volume":"12","author":"Sugimoto","year":"2015","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.disamonth.2017.12.001_bib291","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/acta.0.0490479","article-title":"The effect of metformin on weight loss in obesity","volume":"49","author":"Pedersen","year":"1965","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.disamonth.2017.12.001_bib292","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1530\/acta.0.0570683","article-title":"Observations on the mechanism of increased weight loss during metformin administration in obesity","volume":"57","author":"Pedersen","year":"1968","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib293","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0163-7258(82)90037-7","article-title":"Drug treatment and obesity","volume":"18","author":"Douglas","year":"1982","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib294","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.ijo.0803695","article-title":"Metformin and body weight","volume":"32","author":"Golay","year":"2008","journal-title":"Int J Obes"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib295","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5114\/aoms.2016.62014","article-title":"The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study","volume":"13","author":"Kujawska-Luczak","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.disamonth.2017.12.001_bib296","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2337\/dc06-1569","article-title":"Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach","volume":"30","author":"Freemark","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib297","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2006-0241","article-title":"Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: Improvement in body composition and fasting insulin","volume":"91","author":"Srinivasan","year":"2006","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib298","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.disamonth.2017.12.001_bib299","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMcpc069023","article-title":"Case 31-2006: A 15-year-old girl with severe obesity","volume":"355","author":"Hoppin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2017.12.001_bib300","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib301","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/63025","article-title":"The magnitude of weight loss induced by meformin is independently associated with BMI at baseline in newly diagnosed type 2 diabetes: post- hoc analysis from data of a phase IV open-labeled trial","author":"Zhou","year":"2017","journal-title":"Adv Clin Exp Med"},{"issue":"15","key":"10.1016\/j.disamonth.2017.12.001_bib302","first-page":"3490","article-title":"The effect of sitagliptin on obese patients with insulin treatment-induced diabetes mellitus","volume":"21","author":"Li","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib303","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/14656566.2017.1323878","article-title":"Diabetes type 2 management: what are the differences between DPP-4 inhibitors and how do you choose?","volume":"18","author":"Munir","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.disamonth.2017.12.001_bib304","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-7753(17)30620-6","article-title":"Weight and type 2 diabetes: new recommendations","volume":"147","author":"G\u00f3mez Huelgas","year":"2016","journal-title":"Med Clin"},{"issue":"7 Suppl. 1","key":"10.1016\/j.disamonth.2017.12.001_bib305","article-title":"Optimizing diabetes treatment in the presence of obesity","volume":"84","author":"Esquivel","year":"2017","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib306","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jcjd.2017.08.241","article-title":"The role of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes","volume":"41","author":"Steen","year":"2017","journal-title":"Can J Diabetes"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib307","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00325481.2017.1256747","article-title":"Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus","volume":"129","author":"Blevins","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/j.disamonth.2017.12.001_bib308","unstructured":"Press release: FDA confirms increased risk of leg and foot amputations with diabetes mellitus medicine canagliflozin. Fox Business 05\/16\/2017. [Assessed 20 November 2017]."},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib309","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/dc16-2427","article-title":"Coadministration of canagliflozin and phentermine for weight management in overweight and obese individuals without diabetes: a randomized clinical trial","volume":"40","author":"Hollander","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib310","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol Rev"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib311","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.clinthera.2005.10.009","article-title":"Pramlintide in the treatment of type 1 and type 2 diabetes mellitus","volume":"27","author":"Ryan","year":"2005","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib312","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/joim.12255","article-title":"Brown adipose tissue and its therapeutic potential","volume":"276","author":"Lidell","year":"2014","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib313","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1055\/s-0033-1348264","article-title":"Brown adipose tissue: research milestones of a potential player in human energy balance and obesity","volume":"45","author":"Zafir","year":"2013","journal-title":"Horm Metab Res"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib314","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/nau.23171","article-title":"Long-term treatment with the beta-3 adrenoceptor agonist, mirabegron ameliorates detrusor overactivity and restores cyclic adenosine monophosphate (cAMP) levels in obese mice","volume":"36","author":"Calmasini","year":"2017","journal-title":"Neurourol Urodyn"},{"issue":"16","key":"10.1016\/j.disamonth.2017.12.001_bib315","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1080\/14656566.2016.1233177","article-title":"Beta3-adrenoreceptor agonist mirabegron \u2013 a potential antiobesity drug?","volume":"17","author":"Hainer","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.disamonth.2017.12.001_bib316","doi-asserted-by":"crossref","DOI":"10.1038\/ijo.2017.155","article-title":"Investigating the effects of Orexin-A on thermogenesis in human deep neck brown adipose tissue","author":"Pino","year":"2017","journal-title":"Int J Obes"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib317","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3945\/an.117.015792","article-title":"Dietary (poly)phenols, brown adipose tissue activation, and energy expenditure: a narrative review","volume":"8","author":"Mele","year":"2017","journal-title":"Adv Nutr"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib318","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/nyas.13413","article-title":"Antibody effects of resveratrol; which tissues are involved","volume":"1403","author":"Fern\u00e1ndez-Quintela","year":"2017","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib319","doi-asserted-by":"crossref","first-page":"18632","DOI":"10.3390\/molecules191118632","article-title":"Resveratrol: anti-obesity mechanisms of action","volume":"19","author":"Aguirre","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.disamonth.2017.12.001_bib320","unstructured":"Fluoxetine (Prozac) and other drugs for treatment of obesity.\u00a0Med Lett Drugs Ther; 1994;36(936):107."},{"key":"10.1016\/j.disamonth.2017.12.001_bib321","series-title":"Anxiety disorders. In: Adolescent Medicine: Pharmacotherapeutics in General, Mental and Sexual Health","first-page":"255","author":"Nazeer","year":"2012"},{"key":"10.1016\/j.disamonth.2017.12.001_bib322","first-page":"e303","volume":"42","author":"Seferian","year":"2013"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib323","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1467-789X.2003.00083.x","article-title":"Treatment of obesity: an update on anti-obesity medications","volume":"4","author":"Halpern","year":"2004","journal-title":"Obes Rev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib324","article-title":"Progress and challenges in anti-obesity pharmacotherapy","author":"Bessessen","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib325","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1053\/j.gastro.2007.03.048","article-title":"Gut hormones and appetite control","volume":"132","author":"Wren","year":"2007","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib326","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2174\/1871527315666160709203525","article-title":"Functions of ghrelin in brain, gut and liver","volume":"15","author":"Stasi","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib327","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1152\/physrev.00031.2014","article-title":"Ghrelin, CCK, GLP-1, and PYY (3-36): secretary controls and physiological roles in eating and glycemia in health, obesity, and after RYGB","volume":"97","author":"Steinert","year":"2017","journal-title":"Physiol Rev"},{"issue":"Suppl. 7","key":"10.1016\/j.disamonth.2017.12.001_bib328","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/ijo.2008.235","article-title":"Gastrointestinal satiety signals","volume":"32","author":"Chaudhri","year":"2008","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib329","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2004.02160.x","article-title":"Ghrelin: more than a natural GH secretagogue and\/or an orexigenic factor","volume":"62","author":"Ghigo","year":"2005","journal-title":"Clin Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.disamonth.2017.12.001_bib330","first-page":"S85","article-title":"Pre-and posprandial acylated ghrelin in obese and normal weight men","volume":"26","author":"Andarini","year":"2017","journal-title":"Asia Pac J Clin Nutr"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib331","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/ijo.2015.256","article-title":"Systematic review and meta-analysis of the effect of meal intake on postprandial appetite-related gastrointestinal hormones in obese children","volume":"40","author":"Nguo","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.disamonth.2017.12.001_bib332","doi-asserted-by":"crossref","DOI":"10.1111\/dom.13020","article-title":"Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease","author":"Abegg","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib333","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nut.2016.08.009","article-title":"Function of obestatin in the digestive system","volume":"34","author":"Xing","year":"2017","journal-title":"Nutrition"},{"key":"10.1016\/j.disamonth.2017.12.001_bib334","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2017.07.007","article-title":"LEPR polymorphism may affect energy balance during weight loss among Brazilians obese adolescents","author":"Corgosinho","year":"2017","journal-title":"Neuropeptides"},{"issue":"Suppl. 2","key":"10.1016\/j.disamonth.2017.12.001_bib335","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/ijo.2009.65","article-title":"Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals","volume":"33","author":"Zheng","year":"2009","journal-title":"Int J Obes"},{"key":"10.1016\/j.disamonth.2017.12.001_bib336","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0083-6729(08)60919-X","article-title":"Clinical aspects of leptin","volume":"54","author":"Sinha","year":"1998","journal-title":"Vitam Horm"},{"key":"10.1016\/j.disamonth.2017.12.001_bib337","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1749-6632.2002.tb04293.x","article-title":"Leptin signaling, adiposity and energy balance","volume":"967","author":"J\u00e9quier","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib338","doi-asserted-by":"crossref","first-page":"e0182801","DOI":"10.1371\/journal.pone.0182801","article-title":"In middle-aged and old obese patients, training intervention reduces leptin level: a meta-analysis","volume":"12","author":"Rost\u00e1s","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.disamonth.2017.12.001_bib339","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.peptides.2014.11.010","article-title":"Is there a role for leptin in the reduction of depression symptoms during weight loss therapy in obese adolescent girls and boys?","volume":"65","author":"de Carvalho-Ferreira","year":"2015","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib340","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.peptides.2011.04.025","article-title":"Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss","volume":"32","author":"D\u00e2maso","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.disamonth.2017.12.001_bib341","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jchemneu.2014.05.004","article-title":"The neuroanatomical function of leptin in the hypothalamus","volume":"61-62","author":"Van Swieten","year":"2014","journal-title":"J Chem Neuroanat"},{"issue":"Pt 2","key":"10.1016\/j.disamonth.2017.12.001_bib342","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mce.2015.08.022","article-title":"A talk between fat tissue, gut, pancreas and brain to control body weight","volume":"418","author":"Wilson","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib343","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2174\/1389450118666170227153940","article-title":"Current drug targets in obesity pharmacotherapy \u2013 a review","volume":"18","author":"Bhat","year":"2017","journal-title":"Curr Drug Targets"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib344","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/jc.2016-3628","article-title":"Effect of metreleptin in pediatric patients with lipodystrophy","volume":"102","author":"Brown","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fmed.2017.00069","article-title":"Celastrol: a spectrum of treatment opportunities in chronic diseases","volume":"4","author":"Cesc\u00e3o","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.disamonth.2017.12.001_bib346","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-3-319-41334-1_12","article-title":"Celastrol and its role in controlling chronic diseases","volume":"928","author":"Venkatesha","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib347","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fendo.2017.00047","article-title":"Cholecystokinin-from local gut hormone to ubiquitous messenger","volume":"8","author":"Rehfeld","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib348","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tem.2016.04.002","article-title":"Metabolic actions of the type 1 cholecystokinin receptors: its potential as a therapeutic target","volume":"27","author":"Miller","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib349","first-page":"1","article-title":"A brief review of salient factors influencing adult eating behavior","author":"Emilien","year":"2017","journal-title":"Nutr Res Rev"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib350","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11102-016-0785-3","article-title":"New medical therapies on the horizon: oral octreotide","volume":"20","author":"Biermasz","year":"2017","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib351","first-page":"220","article-title":"Hypothalamic obesity: causes, consequences, treatment","volume":"6","author":"Lustig","year":"2008","journal-title":"Pediatr Endocrinol Rev"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib352","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3892\/etm.2015.2853","article-title":"Pediatric obesity: causes, symptoms, prevention and treatment","volume":"11","author":"Xu","year":"2016","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib353","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00394-012-0413-6","article-title":"Octreotide alleviates obesity by reducing intestinal glucose absorption and inhibiting low-grade inflammation","volume":"52","author":"Liu","year":"2013","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib354","first-page":"a028415","article-title":"Interleukin-6 family cytokines","author":"Rose-John","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib355","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1210\/en.2012-1024","article-title":"The anorectic effect of CNTF does not require action in leptin-responsive neurons","volume":"153","author":"Stefater","year":"2012","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib356","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrn.2016.24","article-title":"Neurotrophic factor control of satiety and body weight","volume":"17","author":"Xu","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.disamonth.2017.12.001_bib357","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.psyneuen.2016.03.003","article-title":"Neuropeptide Y gene-by-psychosocial stress interaction effect is associated with obesity in a Korean population","volume":"69","author":"Kim","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.disamonth.2017.12.001_bib358","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.physbeh.2016.04.049","article-title":"The effect of obesogenic diets on brain neuropeptide Y","volume":"162","author":"Gumbs","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.disamonth.2017.12.001_bib359","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nutres.2017.05.011","article-title":"Intraventricular administration of Tenebrio molitor larvae extract regulates food intake and body weight in mice with high-fat diet-induced obesity","volume":"44","author":"Seo","year":"2017","journal-title":"Nutr Res"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib360","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MED.0000000000000216","article-title":"Gastrointestinal hormones and their role in obesity","volume":"23","author":"Choudhury","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib361","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","article-title":"Inhibition of food intake in obese subjects by peptide YY3-36","volume":"349","author":"Batterham","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib362","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1517\/13543784.14.5.647","article-title":"The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity","volume":"14","author":"Small","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.disamonth.2017.12.001_bib363","unstructured":"https:\/\/en.wikipedia.org\/wiki\/Bombesin. [Assessed 20 November 2017]."},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib364","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MED.0b013e3282f3709b","article-title":"Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states","volume":"15","author":"Gonz\u00e1lez","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"9","key":"10.1016\/j.disamonth.2017.12.001_bib365","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1517\/14728222.2015.1056154","article-title":"Bombesin receptor subtype 3as a potential target for obesity and diabetes","volume":"19","author":"Gonz\u00e1lez","year":"2015","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib366","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3892\/ijmm.2015.2090","article-title":"Effect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes","volume":"35","author":"Gonz\u00e1lez","year":"2015","journal-title":"Int J Mol Med"},{"issue":"1-2","key":"10.1016\/j.disamonth.2017.12.001_bib367","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2012.12.025","article-title":"Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes","volume":"367","author":"Ramos-\u00c1lvarez","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib368","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-5728(85)90032-3","article-title":"Neuroendocrine peptide hormones and their receptors in the immune system. Production, processing and action","volume":"10","author":"Blalock","year":"1985","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib369","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.arr.2016.12.005","article-title":"Dietary restriction and lifespan: lessons from invertebrate models","volume":"39","author":"Kapahi","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib370","article-title":"The role of sirtuins in antioxidant and redox signaling","author":"Singh","year":"2017","journal-title":"Antioxid Redox Signal"},{"issue":"16","key":"10.1016\/j.disamonth.2017.12.001_bib371","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2174\/1381612823666170125153334","article-title":"A review of SIRtuins in diabetes","volume":"23","author":"Aditya","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.disamonth.2017.12.001_bib372","first-page":"404","article-title":"A synthesis of prunetin","volume":"18","author":"Iyer","year":"1949","journal-title":"Curr Sci"},{"issue":"12","key":"10.1016\/j.disamonth.2017.12.001_bib373","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja01857a013","article-title":"Genistin (an isoflavone glucoside) and its aglucone, genistein, from soybeans","volume":"63","author":"Walter","year":"1941","journal-title":"J Amer Chem Soc"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib374","doi-asserted-by":"crossref","first-page":"758S","DOI":"10.1093\/jn\/129.3.758S","article-title":"Dietary isoflavones: biological effects and relevance to human health","volume":"129","author":"Setchell","year":"1999","journal-title":"J Nutr"},{"issue":"1-3","key":"10.1016\/j.disamonth.2017.12.001_bib375","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2012.11.013","article-title":"Genistein: a promising therapeutic agent for obesity and diabetes treatment","volume":"698","author":"Behloul","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib376","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1039\/C2FO30199G","article-title":"Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic \u03b2-cell function","volume":"4","author":"Gilbert","year":"2013","journal-title":"Food Funct"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib377","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/aje\/kwx136","article-title":"Phenol concentrations during childhood and subsequent measures of adiposity among young girls","volume":"186","author":"Deierlein","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib378","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ejcn.2014.23","article-title":"Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein","volume":"68","author":"Frankenfeld","year":"2014","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib379","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/02793695-20150219-01","article-title":"Aspergillus, angiogenesis, and obesity: the story behind beloranib","volume":"53","author":"Howland","year":"2015","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.disamonth.2017.12.001_bib380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/DMSO.S56924","article-title":"Inhibition of the methioninem aminopeptidase 2 enzyme for the treatment of obesity","volume":"7","author":"Joharapurkar","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib381","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/1381612822666151209153047","article-title":"Approaches for the development of drugs for treatment of obesity and metabolic syndrome","volume":"22","author":"Maksimov","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib382","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/dom.12457","article-title":"Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial","volume":"17","author":"Kim","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib383","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/dom.12928","article-title":"A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity","volume":"19","author":"Shoemaker","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib384","doi-asserted-by":"crossref","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Syndrome: a randomized, double-blind, placebo-controlled trial","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.disamonth.2017.12.001_bib385","first-page":"1782","volume":"21","author":"Hughes","year":"2013"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib386","first-page":"729","article-title":"Primum non nocere: first do no harm","volume":"85","author":"Steele","year":"1957","journal-title":"Med Times"},{"key":"10.1016\/j.disamonth.2017.12.001_bib387","first-page":"1105","article-title":"Tesofensine, a monoamine reuptake inhibitor for treatment of obesity","volume":"10","author":"Bello","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"issue":"41","key":"10.1016\/j.disamonth.2017.12.001_bib388","first-page":"2974","article-title":"The effect of tesofensine on body weight and body composition in obese subjects\u2014secondary publication [Article in Danish]","volume":"171","author":"Nielsen","year":"2009","journal-title":"Ugeskr Laeger"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib389","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1074248413501017","article-title":"New and emerging drug molecules against obesity","volume":"19","author":"George","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.disamonth.2017.12.001_bib390","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/npp.2010.16","article-title":"Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat","volume":"35","author":"Axel","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.disamonth.2017.12.001_bib391","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pbb.2013.07.018","article-title":"Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat","volume":"110","author":"Hansen","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.disamonth.2017.12.001_bib392","first-page":"553","volume":"20","author":"Gilbert","year":"2012"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib393","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.euroneuro.2013.10.007","article-title":"Tesofensine, a novel triple monoamine re- uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET","volume":"24","author":"Appel","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9887","key":"10.1016\/j.disamonth.2017.12.001_bib394","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(13)61563-9","article-title":"Under-reporting of adverse effects of tesofensine","volume":"382","author":"Astrup","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib395","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4274\/jcrpe.4225","article-title":"Melanocortin-4 receptor gene mutations in a group of Turkish obese children and adolescents","volume":"9","author":"Tun\u00e7","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib396","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/B978-0-12-386933-3.00005-4","article-title":"Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis","volume":"114","author":"Hinney","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib397","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0706929","article-title":"The MC4 receptor and control of appetite","volume":"149","author":"Adan","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib398","first-page":"612","volume":"20","author":"Mul","year":"2012"},{"key":"10.1016\/j.disamonth.2017.12.001_bib399","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.bbadis.2017.05.007","article-title":"Melanocortin neurons: multiple routes to regulation of metabolism","volume":"1863","author":"Shen","year":"2017","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib400","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1210\/jc.2014-4024","article-title":"RM 493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy in obese individuals","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib401","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/db12-0598","article-title":"Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques","volume":"62","author":"Kievit","year":"2013","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib402","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/JOE-13-0284","article-title":"Novel \u03b1-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity","volume":"220","author":"Fosgerau","year":"2014","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib403","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ijo.2013.80","article-title":"The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options","volume":"38","author":"Fani","year":"2014","journal-title":"Int J Obes"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib404","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4155\/ppa.15.1","article-title":"Melanocortin-4 receptor modulators for the treatment of obesity: a patent analysis (2008-2014)","volume":"4","author":"Lee","year":"2015","journal-title":"Pharm Pat Anal"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib405","first-page":"177","article-title":"Vaccines","volume":"7","author":"Patek","year":"1909","journal-title":"Cal State J Med"},{"key":"10.1016\/j.disamonth.2017.12.001_bib406","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1353\/bhm.0.0173","article-title":"The world\u2019s first immunization campaign: the Spanish smallpox vaccine expedition,1803-1813","volume":"83","author":"Mark","year":"2009","journal-title":"Bull Hist Med"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib407","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2471\/BLT.14.020514","article-title":"The immunization programme that save millions of lives","volume":"92","author":"Reid","year":"2014","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.disamonth.2017.12.001_bib408","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1136\/bmj.g2978","article-title":"US vaccine program will prevent 732,000 deaths, CDC says","volume":"348","author":"McCarthy","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib409","doi-asserted-by":"crossref","first-page":"160","DOI":"10.20344\/amp.5320","article-title":"Do vaccines save lives? Yes they do!","volume":"27","author":"Lernout","year":"2014","journal-title":"Acta Med Port"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib410","first-page":"243","article-title":"A new wave of vaccines for non-communicable diseases: what are the regulatory challenges?","volume":"70","author":"Darrow","year":"2015","journal-title":"Food Drug Law J"},{"issue":"35","key":"10.1016\/j.disamonth.2017.12.001_bib411","doi-asserted-by":"crossref","first-page":"13226","DOI":"10.1073\/pnas.0605376103","article-title":"Vaccination against weight gain","volume":"103","author":"Zorrilla","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib412","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7774\/cevr.2014.3.1.37","article-title":"Prophylactic and therapeutic vaccines for obesity","volume":"3","author":"Na","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib413","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4161\/hv.27537","article-title":"Obesity vaccines","volume":"10","author":"Monteiro","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib414","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/15748847113089990046","article-title":"Endocrinology and immunology of obesity, obesity vaccines","volume":"8","author":"Zjacic-Rotkvic","year":"2013","journal-title":"Curr Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib415","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1586\/erv.11.115","article-title":"Anti-ghrelin vaccine for obesity: a feasible alternative to dieting?","volume":"10","author":"Monteiro","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.disamonth.2017.12.001_bib416","first-page":"123","article-title":"Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy","volume":"4","author":"Altabas","year":"2015","journal-title":"Immunotargets Ther"},{"issue":"40","key":"10.1016\/j.disamonth.2017.12.001_bib417","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1016\/j.vaccine.2016.08.027","article-title":"Hepatitis B vaccine response in obesity: a meta-analysis","volume":"34","author":"Fan","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib418","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10096-015-2558-8","article-title":"Obesity: impact of infections and response to vaccines","volume":"35","author":"Tagliabue","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib419","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1089\/chi.2016.0176","article-title":"Association of childhood obesity and the immune system: a systematic review of reviews","volume":"13","author":"Kelishadi","year":"2017","journal-title":"Child Obes"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib420","first-page":"39","article-title":"Chinese medicine; ancient and modern","volume":"23","author":"Kilborn","year":"1946","journal-title":"Can Hosp"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib421","first-page":"66","article-title":"The merits of the Ayurvedic system of medicine","volume":"58","author":"Roy","year":"1923","journal-title":"Ind Med Gaz"},{"key":"10.1016\/j.disamonth.2017.12.001_bib422","first-page":"177","article-title":"The eternal glory of Ayurveda","volume":"15","author":"Ayyar","year":"1946","journal-title":"Curr Sci"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib423","first-page":"45","article-title":"Plant resources for Ayurveda: an outlook for the future","volume":"3","author":"Sivarajan","year":"1983","journal-title":"Anc Sci Life"},{"issue":"1684","key":"10.1016\/j.disamonth.2017.12.001_bib424","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bmj.1.1684.748","article-title":"Ancient Egyptian medicine: [A bibliographical demonstration in the library of the faculty of Physicians and Surgeons, Glasgow, January 12th. 1893]","volume":"1","author":"Finlayson","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/j.disamonth.2017.12.001_bib425","unstructured":"Scholl R. Der Papyrus Ebers. Die gr\u00f6sste Buchrolle zur Heilkunde Alt\u00e4gyptens (Schriften aus der Universit\u00e4tsbibliothek 7), Leipzig, Germany; 2002."},{"key":"10.1016\/j.disamonth.2017.12.001_bib426","series-title":"The Greatest Benefit of Mankind: A Medical History of Humanity","author":"Porter","year":"1998"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib427","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.drudis.2014.03.018","article-title":"An overview of FDA-approved new molecular entities: 1827-2013","volume":"19","author":"Kinch","year":"2014","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib428","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00001888-200103000-00010","article-title":"The importance of using scientific principles in the development of medicinal agents from plants","volume":"76","author":"Talalay","year":"2001","journal-title":"Acad Med"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib429","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2105\/AJPH.75.1.18","article-title":"Industry invites regulation: the passage of the Pure Food and Drug Act of 1906","volume":"75","author":"Barkan","year":"1985","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib430","first-page":"12","article-title":"Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act","volume":"44","author":"Cooper","year":"2002","journal-title":"Pharm Hist"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib431","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/260107","article-title":"An evaluation of consumer protection legislation: the 1962 drug amendments","volume":"81","author":"Peltzman","year":"1973","journal-title":"J Political Econ"},{"issue":"3-4","key":"10.1016\/j.disamonth.2017.12.001_bib432","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dta.1919","article-title":"The history of efforts to regulate dietary supplements in the USA","volume":"8","author":"Swann","year":"2016","journal-title":"Drug Test Anal"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib433","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/dta.1980","article-title":"Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs)","volume":"9","author":"Pawar","year":"2017","journal-title":"Drug Test Anal"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib434","first-page":"577","article-title":"FDA\u2019s expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce \u201ctransparency\u201d policy harms in the post-9\/11 regulatory environments","volume":"64","author":"Roller","year":"2009","journal-title":"Food Drug Law J"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib435","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.2009.263","article-title":"FDA regulation of dietary supplements and requirements regarding adverse event reporting","volume":"87","author":"Frankos","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib436","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/009885881203800401","article-title":"The ethics of postmarketing observational studies of drug safety under section 505(o)(3) of the Food, Drug, and Cosmetic Act","volume":"38","author":"Evans","year":"2012","journal-title":"Am J Law Med"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib437","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2251-6581-12-28","article-title":"A systematic review of anti-obesity medicinal plants-an update","volume":"12","author":"Hasani-Ranjbar","year":"2013","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.disamonth.2017.12.001_bib438","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.biopha.2017.02.108","article-title":"Medicinal plants and phytochemicals with anti-obesogenic potentials: A review","volume":"89","author":"Mopuri","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib439","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jbcpp-2016-0090","article-title":"The effect of caffeine on energy balance","volume":"28","author":"Harpaz","year":"2017","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib440","doi-asserted-by":"crossref","first-page":"15904","DOI":"10.1038\/ncomms15904","article-title":"Caffeine inhibits hypothalamic A1R to excite oxytocin neuron and ameliorate dietary obesity in mice","volume":"8","author":"Wu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.disamonth.2017.12.001_bib441","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2017.03.400","article-title":"Anti-obesity effect of a novel caffeine-loaded dissolving microneedle patch in high-fat obese C57BL\/6J mice","author":"Dangol","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.disamonth.2017.12.001_bib442","series-title":"Pediatric Practice: Sports Medicine","first-page":"63","article-title":"Performance-enhancing drugs and supplements","author":"Greydanus","year":"2009"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib443","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12024-014-9571-6","article-title":"A case of suicide by ingestion of caffeine","volume":"10","author":"Bonsignore","year":"2014","journal-title":"Forensic Sci Med Pathol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib444","first-page":"12","article-title":"Green tea for weight loss and weight maintenance in overweight or abuse adults","author":"Jurgens","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib445","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1039\/C7FO00611J","article-title":"Healthy properties of green and white teas: an update","volume":"8","author":"Pastoriza","year":"2017","journal-title":"Food Funct"},{"key":"10.1016\/j.disamonth.2017.12.001_bib446","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nut.2017.06.022","article-title":"Effect of green tea on plasma leptin and ghrelin levels: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"45","author":"Haghighatdoost","year":"2018","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib447","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2251-6581-12-28","article-title":"A systemic review of anti-obesity medicinal plants-an update","volume":"12","author":"Hasani-Ranjbar","year":"2013","journal-title":"J Diabetes Metab Disord"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib448","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3945\/ajcn.2008.27043","article-title":"Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss","volume":"89","author":"Hursel","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib449","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00394-016-1206-0","article-title":"Coffee consumption, obesity and type 2 diabetes: a mini-review","volume":"55","author":"Santos","year":"2016","journal-title":"Eur J Nutr"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib450","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1021\/jf9039205","article-title":"Isoflavones in coffee: influence of species, roast degree, and brewing method","volume":"58","author":"Alves","year":"2010","journal-title":"J Agric Food Chem"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib451","doi-asserted-by":"crossref","first-page":"e0149676","DOI":"10.1371\/journal.pone.0149676","article-title":"The dietary isoflavone daidzein reduces expression of pro-inflammatory genes through PPAR\u03b1\/\u03b3 and JNK pathways in adipocyte and macrophage co-cultures","volume":"11","author":"Sakamoto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.disamonth.2017.12.001_bib452","doi-asserted-by":"crossref","DOI":"10.1177\/1178638817710666","article-title":"Effect of supplemetation with chitosan on weight, cardiometabolic, and other risk indices in Wistar rats fed normal and high- fat\/high-cholesterol diets ad libitum","volume":"10","author":"Bahijri","year":"2017","journal-title":"Nutr Metab Insights"},{"key":"10.1016\/j.disamonth.2017.12.001_bib453","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.carbpol.2016.10.042","article-title":"Enhanced anti-obesity of complex of resistant starch and chitosan in high fat diet fed rats","volume":"157","author":"Si","year":"2017","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.disamonth.2017.12.001_bib454","article-title":"Chitosan for overweight or obesity","volume":"3","author":"Jull","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib455","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1467-789X.2005.00158.x","article-title":"Effect of chitosan on weight loss in overweight and obese individuals: a systematic review of \/randomized controlled trials","volume":"6","author":"Mhurchu","year":"2005","journal-title":"Obes Rev"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib456","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/09637486.2011.640310","article-title":"Use of chitosan in the treatment of obesity: evaluation of interaction with vitamin B12","volume":"63","author":"Rodrigues","year":"2012","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib457","article-title":"Chromium picolinate supplementation for overweight or obese adults","volume":"11","author":"Tian","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib458","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/ptr.3490","article-title":"The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine","volume":"25","author":"Stohs","year":"2011","journal-title":"Phytother Res"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib459","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1248\/bpb.b13-00788","article-title":"p-Synephrine: a novel agonist for neuromedin U2 receptor","volume":"37","author":"Zheng","year":"2014","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib460","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7150\/ijms.4446","article-title":"A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine","volume":"9","author":"Stohs","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.disamonth.2017.12.001_bib461","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.fct.2013.01.013","article-title":"A 60 day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract","volume":"55","author":"Kaats","year":"2013","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib462","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11130-013-0361-1","article-title":"A review on botanical species and compounds with appetite suppressing properties for body weight control","volume":"68","author":"Astell","year":"2013","journal-title":"Plant Foods Hum Nutr"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib463","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/dta.1980","article-title":"Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs)","volume":"9","author":"Pawar","year":"2017","journal-title":"Drug Test Anal"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib464","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/obr.12436","article-title":"The efetfect of (L-)carnitive on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Pooyandjoo","year":"2016","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib465","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.11.125","article-title":"Herbal supplements association with reversible cerebral vasoconstriction syndrome: a case report","volume":"26","author":"Costa","year":"2017","journal-title":"J Stroke Cardiovasc Dis"},{"key":"10.1016\/j.disamonth.2017.12.001_bib466","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.fitote.2015.02.012","article-title":"A comprehensive scientific overview of Garcinia cambogia","volume":"102","author":"Semwal","year":"2015","journal-title":"Fitoterapia"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib467","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10408398.2010.500551","article-title":"Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans","volume":"52","author":"M\u00e1rquez","year":"2012","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"45","key":"10.1016\/j.disamonth.2017.12.001_bib468","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.3748\/wjg.v22.i45.10071","article-title":"Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation","volume":"22","author":"Lunsford","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib469","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5604\/16652681.1184287","article-title":"Acute liver failure associated with Garcina cambogia use","volume":"15","author":"Corey","year":"2016","journal-title":"Ann Hepatol"},{"issue":"12","key":"10.1016\/j.disamonth.2017.12.001_bib470","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.cjca.2014.08.025","article-title":"Acute necrotizing eosinophilic myocarditis in a patient taking Garcia cambogia extract successfully treated with high-dose corticosteroids","volume":"30","author":"Allen","year":"2014","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib471","article-title":"Mania induced by Garcinia cambogia: a case series","volume":"18","author":"Hendrickson","year":"2016","journal-title":"Prim Care Companion CNS Disorfd"},{"issue":"25","key":"10.1016\/j.disamonth.2017.12.001_bib472","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.3748\/wjg.15.3073","article-title":"A systemic review of the efficacy and safety of herbal medicines used in the treatment of obesity","volume":"15","author":"Hasani-Ranjbar","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib473","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ctim.2013.01.004","article-title":"A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomized, controlled clinical trial","volume":"21","author":"Astell","year":"2013","journal-title":"Complement Ther Med"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib474","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jep.2008.08.023","article-title":"Hoodia gordonii: a natural appetite suppressant","volume":"119","author":"van Heerden","year":"2008","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib475","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s13679-016-0214-y","article-title":"New dietary supplements for obesity: what we currently know","volume":"5","author":"Rios-Hoyo","year":"2016","journal-title":"Curr Obes Rep"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib476","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/jmf.2013.0178","article-title":"Efficacy and acceptance of a commercial Hoodia parviflora product for support of appetite and weight control in a consumer trial","volume":"18","author":"Landor","year":"2015","journal-title":"Med Food"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib477","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jep.2014.06.033","article-title":"Hoodia gordonii: to eat, or not to eat","volume":"155","author":"Smith","year":"2014","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib478","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2710.2009.01116.x","article-title":"Case report. Efficacy of Hoodia for weight loss: is there evidence to support the efficacy claims?","volume":"35","author":"Whelan","year":"2010","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"10.1016\/j.disamonth.2017.12.001_bib479","doi-asserted-by":"crossref","DOI":"10.3390\/nu9080882","article-title":"Yerba mat\u00e9 (Ilex paraguariensis) metabolic, satiety, and mood state effects at rest and during prolonged exercise","volume":"9","author":"Alkhatib","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.disamonth.2017.12.001_bib480","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1743-7075-11-42","article-title":"Yerba mat\u00e9 (Illex paraguariensis) ingestion augments fat oxidation and energy expenditures during exercise at various submaximal intensities","volume":"11","author":"Alkhatib","year":"2014","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib481","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1467-789X.2005.00169.x","article-title":"Adverse events of herbal food supplements for body weight reduction: systematic review","volume":"6","author":"Pittler","year":"2005","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib482","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12011-016-0776-2","article-title":"Metals content in herbal supplements","volume":"175","author":"Barrella","year":"2017","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.disamonth.2017.12.001_bib483","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1142\/S0192415X0500334X","article-title":"Clinical trial of herbal formula on weight loss in obese Korean children","volume":"33","author":"Yoo","year":"2005","journal-title":"Am J Chin Med"},{"issue":"43","key":"10.1016\/j.disamonth.2017.12.001_bib484","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4103\/0973-1296.160456","article-title":"Traditional medicine yanggyuksanhwa-tang inhibits adipogenesis and suppresses proliferator-activated receptor gamma expression in 3T3-L1 cells","volume":"11","author":"Jeong","year":"2015","journal-title":"Pharmacogn Mag"},{"key":"10.1016\/j.disamonth.2017.12.001_bib485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/J157v05n03_07","article-title":"Ephedra: yesterday, DSHEA, and tomorrow-a ten-year perspective on the dietary supplement health and education act of 1994","volume":"5","author":"Seamon","year":"2005","journal-title":"J Herb Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib486","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1354\/vp.46-1-10","article-title":"Review paper: current strategies in the development of anti-obesity drugs and their safety concerns","volume":"46","author":"Elangbam","year":"2009","journal-title":"Vet Pathol"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib487","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200629040-00001","article-title":"Safety of drug therapies used for weight loss and treatment of obesity","volume":"29","author":"Ioannides-Demos","year":"2006","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib488","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1074248414531852","article-title":"Food and drug administration regulation of drugs that raise blood pressure","volume":"20","author":"Blankfield","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib489","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1136\/hrt.2004.036491","article-title":"Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure","volume":"90","author":"Barst","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.disamonth.2017.12.001_bib490","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1525-1497.2003.20130.x","article-title":"Adverse drug event monitoring at the Food and Drug Administration","volume":"18","author":"Ahmad","year":"2003","journal-title":"J Gen Inter Med"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib491","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/aje\/kws427","article-title":"Use of decongestants during pregnancy and the risk of birth defects","volume":"178","author":"Yau","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib492","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10741-017-9612-9","article-title":"Drug-induced pulmonary artery hypertension: a review","volume":"22","author":"Garg","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib493","unstructured":"Sibutramine for obesity. Med Lett Dr Ther 1998;40:32."},{"issue":"6","key":"10.1016\/j.disamonth.2017.12.001_bib494","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/dom.12657","article-title":"Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles","volume":"18","author":"Krentz","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib495","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.jcp.0000270083.38124.1f","article-title":"Psychosis with sibutramine","volume":"27","author":"Rosenbohm","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib496","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-244X-12-43","volume":"12","author":"Waszkiewicz","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib497","doi-asserted-by":"crossref","first-page":"18452","DOI":"10.4238\/2015.December.23.33","article-title":"Can Spirulina maxima reduce the mutagenic potential of sibutramine?","volume":"14","author":"Araldi","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.disamonth.2017.12.001_bib498","first-page":"3","article-title":"Long-term effects of weight-reducing drugs in people with hypertension","author":"Siebenhofer","year":"2016","journal-title":"Cochrane Data Syst Rev"},{"key":"10.1016\/j.disamonth.2017.12.001_bib499","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpba.2013.10.038","article-title":"Dose-to-dose variations with single packages of counterfeit medicines and adulterated dietary supplements as a potential source of false negatives and inaccurate health risk assessments","volume":"89","author":"Venhuis","year":"2014","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib500","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/19440049.2013.861934","article-title":"Screening and determination of sibutramine in adulterated herbal slimming supplements by HPTLC-UV densitometry","volume":"31","author":"Mathon","year":"2014","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib501","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/19440049.2014.888497","article-title":"Monitoring of 29 weight loss compounds in foods and dietary supplement by LC-MS\/MS","volume":"31","author":"Kim","year":"2014","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib502","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/WNF.0000000000000141","article-title":"A rare case of psychomotor disturbances linked to the use of an adulterated dietary supplement containing subutramine","volume":"39","author":"Shapira","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib503","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(05)66348-9","article-title":"Fighting obesity and associated risk factors by antagonizing cannabinoid type 1 receptors","volume":"365","author":"Pagotto","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2017.12.001_bib504","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1- receptor blocker on weight and cardiometabolic risk factors in overweight or obese patients","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib505","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib506","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","article-title":"Blockage of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716","volume":"58","author":"Huestis","year":"2001","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib507","unstructured":"FDA Briefing Document NDA 21-888 Zimulti (rimonabant) tablets, 20. FDA. June 13, 2007. [Assessed 20 November 2017]."},{"key":"10.1016\/j.disamonth.2017.12.001_bib508","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-319-63260-5_4","article-title":"Hypothalamic dysfunction in obesity and metabolic disorders","volume":"19","author":"Carmo-Silva","year":"2017","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.disamonth.2017.12.001_bib509","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000475737","article-title":"Treatment of diabetes and obesity by rationally designed peptide agonists functioning at multiple metabolic receptors","volume":"32","author":"Khajavi","year":"2017","journal-title":"Endocr Dev"},{"issue":"3","key":"10.1016\/j.disamonth.2017.12.001_bib510","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0300985813492801","article-title":"Models and strategies in the development of antiobesity drugs","volume":"51","author":"Agahi","year":"2014","journal-title":"Vet Pathol"},{"issue":"20","key":"10.1016\/j.disamonth.2017.12.001_bib511","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4239\/wjd.v7.i20.572","article-title":"Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity","volume":"7","author":"Anandhakrishnan","year":"2016","journal-title":"World J Diabetes"},{"key":"10.1016\/j.disamonth.2017.12.001_bib512","first-page":"1","article-title":"Can we win the war on obesity with pharmacotherapy?","author":"Gotthardt","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3)","key":"10.1016\/j.disamonth.2017.12.001_bib513","article-title":"Long-term pharmacotherapy for obesity and overweight","author":"Padwal","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib514","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11892-017-0859-2","article-title":"Pharmacotherapy of obesity: clinical trials to clinical practice","volume":"17","author":"Gadde","year":"2017","journal-title":"Curr Diab Res"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib515","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mcna.2017.08.010","article-title":"Obesity pharmacotherapy","volume":"102","author":"Saunders","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.disamonth.2017.12.001_bib516","series-title":"The SAGES Manual: Volume 2 577 Advanced Laparoscopy and Endoscopy","year":"2012"},{"key":"10.1016\/j.disamonth.2017.12.001_bib517","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/oby.2008.577","article-title":"Best practice updates for pediatric\/adolescent weight loss surgery","volume":"17","author":"Pratt","year":"2009","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.disamonth.2017.12.001_bib518","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/SLA.0b013e31818702f4","article-title":"Systematic review and meta-analysis of bariatric surgery for pediatric obesity","volume":"248","author":"Treadwell","year":"2008","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib519","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1542\/peds.114.1.217","article-title":"Bariatric Surgery for severely overweight adolescents: concerns and recommendations","volume":"114","author":"Inge","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib520","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamapediatrics.2013.4296","article-title":"Perioperative Outcome of Adolescents Undergoing Bariatric Surgery: The Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Study","volume":"168","author":"Inge","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"7","key":"10.1016\/j.disamonth.2017.12.001_bib521","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1381\/0960892054621125","article-title":"Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels","volume":"15","author":"Langer","year":"2005","journal-title":"Obese Surg"},{"key":"10.1016\/j.disamonth.2017.12.001_bib522","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/SLA.0b013e318251e92b","article-title":"Laparoscopic sleeve gastrectomy in 108 obese children and adolescents aged 5\u201321 years","volume":"256","author":"Alqahtani","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.disamonth.2017.12.001_bib523","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.soard.2011.11.021","article-title":"Laparoscopic sleeve gastrectomy in obese adolescents: results in 51 patients","volume":"8","author":"Boza","year":"2012","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib524","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2008-1038356","article-title":"Laparoscopic sleeve gastrectomy achieves substantial weight loss in an adolescent girl with morbid obesity","volume":"18","author":"Till","year":"2008","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.disamonth.2017.12.001_bib525","unstructured":"Landau Z, Karplus G, Hanukoglu A, et al. Laparoscopic sleeve gastrectomy (LSG) in adolescents with morbid obesity. Harefuah 2011;150(10):765-8, 816, 815."},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib526","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.surg.2012.05.010","article-title":"Early results after laparoscopic sleeve gastrectomy in adolescents with morbid obesity","volume":"152","author":"Nadler","year":"2012","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib527","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mcna.2017.08.011","article-title":"Bariatric surgery for obesity","volume":"102","author":"le Roux","year":"2018","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib528","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1067\/mpd.2001.113043","article-title":"Gastric bypass surgery in adolescents with morbid obesity","volume":"138","author":"Strauss","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.disamonth.2017.12.001_bib529","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1091-255X(02)00125-7","article-title":"Bariatric surgery for severely obese adolescents","volume":"7","author":"Sugerman","year":"2003","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib530","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpedsurg.2007.09.035","article-title":"An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data","volume":"43","author":"Nadler","year":"2008","journal-title":"J Pediatr Surg"},{"issue":"2","key":"10.1016\/j.disamonth.2017.12.001_bib531","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MPG.0b013e31805b82fb","article-title":"Initial experience with the adjustable gastric band in morbidly obese US adolescents and recommendations for further investigation","volume":"45","author":"Dillard","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.disamonth.2017.12.001_bib532","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1007\/s11695-017-2699-1","article-title":"Efficacy of intragastric balloon treatment for adolescent obesity","volume":"27","author":"Fittipaldi-Fernandez","year":"2017","journal-title":"Obes Surg"},{"issue":"4","key":"10.1016\/j.disamonth.2017.12.001_bib533","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1381\/0960892053723411","article-title":"Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in nonmorbid obese patients","volume":"15","author":"Mion","year":"2005","journal-title":"Obes Surg"},{"key":"10.1016\/j.disamonth.2017.12.001_bib534","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jpedsurg.2008.02.078","article-title":"Health-related quality of life before and after bariatric surgery in adolescents","volume":"43","author":"Loux","year":"2008","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib535","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2008-0522","article-title":"Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents","volume":"123","author":"Inge","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.disamonth.2017.12.001_bib536","series-title":"Obesity Surgery: Principles and Practice","article-title":"Adolescent Bariatric Surgery","author":"Chandra","year":"2008"},{"issue":"Suppl 4","key":"10.1016\/j.disamonth.2017.12.001_bib537","first-page":"53","article-title":"Prevention of obesity from perinatal stage","volume":"34","author":"Mart\u00ednez Garcia","year":"2017","journal-title":"[article in Spanish]. Nutr Hosp"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib538","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mcna.2017.08.008","article-title":"Obesity in pregnancy: optimizing outcomes for mom and baby","volume":"102","author":"Dutton","year":"2018","journal-title":"Med Clin North Am"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib539","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.chc.2017.08.003","article-title":"A review of the prevention and medical management of childhood obesity","volume":"27","author":"Anderson","year":"2018","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"1","key":"10.1016\/j.disamonth.2017.12.001_bib540","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mcna.2017.08.006","article-title":"Guidelines recommendations for obesity management","volume":"102","author":"Ryan","year":"2018","journal-title":"Med Clin North Am"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001150291730192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001150291730192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T11:25:38Z","timestamp":1719746738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001150291730192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":540,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S001150291730192X"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2017.12.001","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric obesity: Current concepts","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}